- •LIVER DISEASES
- •LIVER DISEASES
- •Do you know that …
- •Liver structure v. portae system
- •Liver
- •Liver functions
- •Major risk factors for liver disease
- •Symptoms of liver disorders
- •Fatigue
- •Jaundice
- •Jaundice or icterus
- •Jaundice: major types
- •Causes of jaundice
- •Darkening of the Urine
- •Pale (light) Stools
- •Liver Pain
- •Ascites
- •Ascites, umbilical hernia
- •Ascites
- •Симптомы и синдромы заболеваний печени
- •ПОРТАЛЬНАЯ ГИПЕРТЕНЗИЯ
- •Possible levels of block in portal hypertension
- •Hepatocellular cytolisis
- •Stigmata of chronic liver disease
- •Cholestasis syndrom
- •CHOLESTASIS
- •Etiology of Dupuitren contracture
- •Etiologic factors of gynecomastia
- •polyneuropathia
- •ПРИЧИНЫ ПОРТАЛЬНОЙ ГИПЕРТЕНЗИИ
- •Расширенные вены передней стенки живота, асцит
- •ЭГДС.
- •Расширение v. рortae и vv. hepaticae
- •ПЕЧЕНОЧНОКЛЕТОЧНАЯ
- •ПРИЧИНЫ ПЕЧЕНОЧНОЙ НЕДОСТАТОЧНОСТИ
- •Синдром печеночно-клеточной недостаточности
- •Печеночная энцефалопатия
- •ГЕПАТОРЕНАЛЬНЫЙ СИНДРОМ I и II тип
- •Патогенеза гепаторенального синдрома
- •Типы гепаторенального синдрома
- •ФАКТОРЫ, ПРОВОЦИРУЮЩИЕ РАЗВИТИЕ ГЕПАТОРЕНАЛЬНОГО СИНДРОМА (на фоне поражения печени)
- •Желтуха, ксантелазмы
- •ГИПЕРСПЛЕНИЗМ
- •Маркеры хронической алкогольной интоксикации
- •Классификация тяжести поражения печени по Чайлд-Пью
- •ЭГДС – расширенные вены пищевода
- •Пункционная биопсия печени под контролем УЗИ (цирроз)
- •Мелкоочаговое поражение печени при остром гепатите
- •Асцит, расширенная v.portae, неровность контуров при циррозе печени
- •Сцинтиграфия печени с метастазами
- •Сцинтиграфия мелкоузлового цирроза
- •Лапароскопия – крупноузловой цирроз
- •Передняя стенка живота при синдроме портальной гипертензии
- •Компьютерная томография
- •FibroScan®
- •Выраженность фиброза при фибросканировании печени
- •Stages of Liver Disease
- •Progression of Hepatitis B Infection
- •Healthy Liver
- •Healthy Liver
- •Types of Hepatitis
- •Hepatitis B is a Devastating Global Healthcare Issue
- •Hepatitis – Disease Terminology
- •How Hepatitis B is Acquired?
- •How the Infection is Acquired in the West?
- •Hepatitis B – Diagnosis Terminology
- •Diagnosis of Chronic Hepatitis B
- •Signs and Symptoms of HBV Infection
- •Universal Hepatitis B Vaccination
- •Global Control of Hepatitis B
- •Types of viral Hepatitis
- •Healthy Liver
- •Liver biopsy
- •Detection of serologic markers of hepatitis B virus (HBV) infection, as a function
- •Lamivudine is a Potent Inhibitor of HBV Replication
- •Lamivudine has an Excellent Pharmacokinetic Profile
- •Patient Entry Criteria
- •One Year of Lamivudine - Conclusions
- •Resistance to Anti-Viral Drugs
- •Prevention of Hepatitis B
- •Universal Hepatitis B Vaccination
- •Recommendations for Pre-exposure Vaccination
- •Recommendations for Post-exposure Vaccination
- •Global Control of Hepatitis B
- •Concurrent immunologic diseases in type 2 autoimmune hepatitis.
- •Probabilities of clinical, biochemical, and histologic remission during corticosteroid therapy.
- •Clinical features of type 2 autoimmune hepatitis.
- •Liver transplantation for autoimmune hepatitis.
- •Survival expectations and probability of developing cirrhosis during and after corticosteroid treatment.
- •liver biopsy
- •Detection of serologic markers of hepatitis B virus (HBV) infection, as a function
- •The Efficacy and Safety of Lamivudine in HBeAg-positive Chronic Hepatitis B
- •Lamivudine is a Potent Inhibitor of HBV Replication
- •Lamivudine has an Excellent Pharmacokinetic Profile
- •What Patient Populations Have Been Studied
- •Key Lamivudine Clinical Studies (1)
- •Key Lamivudine Clinical Studies (2)
- •Patient Entry Criteria
- •Lamivudine Rapidly Suppresses
- •One Year of Lamivudine - Conclusions
- •Resistance to Anti-Viral Drugs
- •Concurrent immunologic diseases in type 1 autoimmune hepatitis.
- •Probabilities of clinical, biochemical, and histologic remission during corticosteroid therapy.
- •Clinical features of type 2 autoimmune hepatitis.
- •Liver transplantation for autoimmune hepatitis.
- •Survival expectations and probability of developing cirrhosis during and after corticosteroid treatment.
- •ALCOHOLIC LIVER DISEASE
- •Principal alcohol-induced hepatic lesions
- •Alcohol-induced hepatic lesions
- •Pathogenesis of liver injury secondary to chronic ethanol ingestion
- •Equivalents of pure alcohol
- •Alcoholic fatty liver
- •Two-Hit Model of the Progression of Fatty Liver Disease
- •Alcoholic fatty liver
- •Similarities between Alcoholic and Nonalcoholic Fatty Liver Diseases
- •Alcoholic hepatitis
- •This figure depicts a laparoscopic view of a patient with chronic active hepatitis
- •Percutaneous liver biopsy with or without ultrasonic guidance
- •Alcoholic hepatitis: liver biopsy
- •Treatment of severe alcoholic hepatitis
- •Причины смерти при алкогольном гепатите
- •Alcoholic cirrhosis
- •Alcoholic cirrhosis
- •Alcoholic cirrhosis: clinical manifestations
Hepatitis B is a Devastating Global Healthcare Issue
75% of long-term carriers live in Asia Pacific5
•350 million long-term carriers worldwide1
•Up to 25% will die due to hepatitis B or related complications2
•Around 1 million die each year from HBV infection3, making it the 9th leading cause of death worldwide4
1 WHO 1998; 2 Mast 1993; 3 Lee 1997; 4Boag 1991; 5 Gust 1996
Hepatitis – Disease Terminology
Acute hepatitis
Short-term hepatitis, during which the body’s immune system clears the virus from the body within 6 months
Chronic hepatitis
Long-term hepatitis, in which the infection persists beyond 6 months because the body’s immune system cannot clear the virus from the body
How Hepatitis B is Acquired?
•In the Asia Pacific region, most people acquire the virus at or near the time of birth1 - 9 out of 10 of those infected with hepatitis B will still be infected when they reach adulthood2
•In the rest of the world, hepatitis B virus is more likely acquired in adolescence or adult life through sexual contact or exposure to contaminated blood1
1 Margolis et al. 1991; 2 Thomas 1996
How the Infection is Acquired in the West?
Transfusion and |
Newborns of long-term |
transplant recipients |
carriers |
Individuals with |
Intravenous |
|
multiple |
||
drug users |
||
sexual partners |
||
|
Healthcare |
Prisoners and other |
workers |
institutionalised people |
Hepatitis B – Diagnosis Terminology
HBeAg |
Viral protein produced when virus |
|
replicates |
|
|
HBV DNAGenetic material of the hepatitis B virus |
||
ALT/AST |
Liver enzymes (proteins)-detected at high |
|
levels in blood when liver cells are |
damaged |
HistologyLiver tissue sample seen under the microscope to assess liver damage
Diagnosis of Chronic Hepatitis B
•Medical history and physical examination
•Tests needed because majority of patients have no symptoms
•Blood Tests
–Viral replication (HBV DNA and HBeAg levels)
–Liver damage (liver enzymes - ALT/AST)
•Liver tissue sample (histology) - allows determination of the extent of liver damage
Signs and Symptoms of HBV Infection
The majority of patients with chronic hepatitis B have no symptoms
Short-Term Infection
•Tiredness or “flu-like” symptoms
•Nausea or stomach ache
•Diarrhoea
•Skin rash
•Yellow eyes/skin (jaundice)
•Light-coloured stools
•Dark yellow urine
Long-Term Infection
•Same symptoms as acute
•Muscles and joints ache
•Weakness
•Signs and symptoms of cirrhosis
Universal Hepatitis B Vaccination
The Strategy
•All infants to be immunised before the age of 18 months – regardless of country
•In 1998, 80 countries have achieved this goal
The Experience
•Other childhood vaccines do not interfere with response
•Protection lasts >10 years and booster doses not required
•Screening of pregnant women for HBV markers, ensuring immediate vaccination of infants borne to HBsAg+ve mothers
Global Control of Hepatitis B
•The two most important interventions in the global control of hepatitis B are……….
–the integration of hepatitis B vaccine into national immunisation schedules and
–effective treatment of the many millions of chronic carriers of hepatitis B
Types of viral Hepatitis
Hepatitis How is it acquired?
A Oral via contaminated food or water B Blood/body fluids and mother-to-child C Blood/body fluids and mother-to-child
D Blood/body fluids (only found with hepatitis B virus)
E Oral via contaminated water G Blood
Hoofnagle 1994; Linnen et al. 1996